Favipiravir in patients with early mild-to-moderate COVID-19: a randomized controlled trial
Clinical Infectious Diseases (2022) - Comments
pubmed: 36065065  doi: 10.1093/cid/ciac712  issn: 1058-4838  issn: 1537-6591 

Yoav Golan, Jesus Abraham Simon Campos, Rob Woolson, Donald Cilla, Rodolfo Hanabergh, Yaneicy Gonzales-Rojas, Reynaldo Lopez, Robert Finberg, Armand Balboni